Amikacin or Vancomycin Exposure Alters the Postnatal Serum Creatinine Dynamics in Extreme Low Birth Weight Neonates

Metabolic Bone Disease in Very Low-Birth-Weight Neonates

Background: Metabolic bone diseases (MBD), including rickets and osteopenia, are important neonatal complications among preterm infants. This study aimed to determine the prevalence and risk factors of MBD in neonates with very low birth weight (VLBW). Methods: This prospective study was conducted on VLBW infants from January 2012 to July 2013. Inclusion criteria were birth weight of ≤1500 g a...

Insulin levels in low birth weight neonates.

BACKGROUND & OBJECTIVES Foetal undernutrition may have important role in adult insulin resistance and diabetes but insulin kinetics in very early life has not been well studied. The present study was undertaken to determine insulin levels in low birth weight neonates and compare with the levels in normal weight and high birth weight neonates. METHODS Ten 7 day old children each of low birth w...

Essential care of low birth weight neonates.

13 VOLUME 45__JANUARY 17, 2008 A newborn infant weighing less than 2500g at birth is termed as low birth weight (LBW) neonate. Low birth weight in a newborn infant results due to intrauterine growth restriction (IUGR) or prematurity. According to UNICEF, the incidence of LBW neonates is 30% in India(1). Low birth weight neonates are further classified as very low birth weight (VLBW <1500 g) and...

Care of Low Birth Weight Neonates

Effect of clofibrate on serum triglyceride and cholesterol after intravenous lipid in very low birth weight neonates

Background   Lipoprotein lipase activity can be increased by clofibrate. Clofibrate is used to reduce serum triglyceride level in adults. The aim of this study was to determine the effect of clofibrate on serum triglyceride and cholesterol level after administration of intravenous lipid in very low birth weight neonates. Method In a randomized double blind placebo – controlled study, 60 very lo...